Intrinsic value of Entrada Therapeutics, Inc. (TRDA)
Live fair value data for Entrada Therapeutics, Inc. (TRDA) is currently unavailable. Please check again shortly.
Current Price: $459.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Entrada Therapeutics, Inc. (TRDA) undervalued or overvalued?
Based on the current model output, Entrada Therapeutics, Inc. appears to be undervalued with a upside of 62.00%.
Fair value vs market price — Entrada Therapeutics, Inc. (TRDA)
Unlock premium access to view the live fair value comparison against current market price for TRDA.
Frequently Asked Questions - TRDA
How is TRDA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TRDA.
Is TRDA undervalued or overvalued right now?
TRDA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TRDA: open their intrinsic value pages.